M Dockrell1, M R Partridge, E Valovirta. 1. The European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
Abstract
BACKGROUND: Asthma has a major impact on patients' lives, and severe asthma is a serious health problem. The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) commissioned a telephonic survey to capture the views of people who are living with severe asthma in Europe. METHODS: A total of 1300 patients from the UK, France, Germany, Spain and Sweden who reported a previous diagnosis of asthma and reported receiving asthma medication took part in the survey. RESULTS: Most patients reported having limitations to their lifestyles as a consequence of the symptoms of severe asthma. Almost 70% of patients reported that physical activity was restricted, 50% were restricted from having pets, 30% from taking holidays, and many felt their job prospects were limited. In addition, 50% of this population of patients were not convinced that guideline goals were being achieved, although it is not clear as to the cause of this failing. Patients indicated that they want treatments that are fast-acting, long-lasting and have minimal side effects, and they were optimistic for the development of effective therapies over the next 5 years. CONCLUSIONS: The results of this study provide insight into how greatly patients' lives are affected by severe asthma.
BACKGROUND:Asthma has a major impact on patients' lives, and severe asthma is a serious health problem. The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) commissioned a telephonic survey to capture the views of people who are living with severe asthma in Europe. METHODS: A total of 1300 patients from the UK, France, Germany, Spain and Sweden who reported a previous diagnosis of asthma and reported receiving asthma medication took part in the survey. RESULTS: Most patients reported having limitations to their lifestyles as a consequence of the symptoms of severe asthma. Almost 70% of patients reported that physical activity was restricted, 50% were restricted from having pets, 30% from taking holidays, and many felt their job prospects were limited. In addition, 50% of this population of patients were not convinced that guideline goals were being achieved, although it is not clear as to the cause of this failing. Patients indicated that they want treatments that are fast-acting, long-lasting and have minimal side effects, and they were optimistic for the development of effective therapies over the next 5 years. CONCLUSIONS: The results of this study provide insight into how greatly patients' lives are affected by severe asthma.
Authors: L Dejager; K Dendoncker; M Eggermont; J Souffriau; F Van Hauwermeiren; M Willart; E Van Wonterghem; T Naessens; M Ballegeer; S Vandevyver; H Hammad; B Lambrecht; K De Bosscher; J Grooten; C Libert Journal: Mucosal Immunol Date: 2015-03-11 Impact factor: 7.313
Authors: Jane E Bourke; Yan Bai; Chantal Donovan; James G Esposito; Xiahui Tan; Michael J Sanderson Journal: Am J Respir Cell Mol Biol Date: 2014-04 Impact factor: 6.914
Authors: Chantal Donovan; Mirjam Simoons; James Esposito; Jean Ni Cheong; Meaghan Fitzpatrick; Jane Elizabeth Bourke Journal: Respir Res Date: 2014-03-12
Authors: Matheus Silverio Mattos; Maximiliano Ruben Ferrero; Lucas Kraemer; Gabriel Augusto Oliveira Lopes; Diego Carlos Reis; Geovanni Dantas Cassali; Fabricio Marcus Silva Oliveira; Laura Brandolini; Marcello Allegretti; Cristiana Couto Garcia; Marco Aurélio Martins; Mauro Martins Teixeira; Remo Castro Russo Journal: Front Immunol Date: 2020-10-02 Impact factor: 7.561
Authors: Michelle A Stubbs; Vanessa L Clark; Melissa Mei Yin Cheung; Lorraine Smith; Bandana Saini; Janelle Yorke; Eleanor C Majellano; Peter G Gibson; Vanessa M McDonald Journal: J Asthma Allergy Date: 2021-12-17